Publication Details
Abstract
Nanotechnology is revolutionizing the field of medical diagnostics by enabling earlier, faster, and more accurate disease detection through innovations in chemical analysis. Despite recent advancements, a significant knowledge gap remains in translating nanoscale analytical techniques into clinically viable, point-of-care diagnostics with high sensitivity and specificity. This article explores the integration of nanomaterials—including nanoparticles, quantum dots, and biosensors—into chemical analysis tools such as spectroscopy, chromatography, and microfluidic systems. A multidisciplinary methodology is used to assess these innovations across detection platforms, highlighting their enhanced signal amplification, real-time detection capabilities, and suitability for biomarker discovery. The implications of this work suggest that nanotechnology can significantly improve early diagnostic outcomes, especially for chronic and life-threatening diseases, though regulatory, standardization, and interdisciplinary challenges must be addressed to achieve full clinical adoption.